Rebyota
AGA Offers New Guidance on FMT Therapies To Prevent C. diff
Treatment with FMT is effective for preventing recurrent Clostridioides difficile infection in adults with robust ...
APRIL 18, 2024
Gut Tech: Better Detection of CDI Reduces Illness and Recurrence
A two-step algorithm for Clostridioides difficile infection (CDI) testing may reduce unnecessary treatment and ...
AUGUST 28, 2023
A New Era for Managing Clostridioides difficile Infection
In the last decade, we have started to understand the critical components of the gut microbiome that prevent C. ...
APRIL 3, 2023
Phase 3 Data Show Rebyota Safe, Effective in Reducing Recurrent CDI
The FDA approved the microbiota-based live biotherapeutic RBX2660 (Rebyota, Ferring) to prevent recurrent ...
DECEMBER 10, 2022
Load more